If anyone here is useing this, it made the CBS news last night and you should go read this...
http://www.pharmabiz.com/article/det...rticleid=48462

It states
After reviewing a comprehensive benefit-risk re-assessment submitted by Merck Serono, the EMEA's Committee for Medicinal Products for Human Use (CHMP) has now concluded that the benefits of Raptiva no longer outweigh its risks.